Psoriasis and obesity share common pathogenic mechanisms, i.e., increased production of pro-inflammatory cytokines (IL-1, IL-6, TNF-α, and adiponectin) which are responsible for a chronic low-grade inflammation which are observed in both conditions [51]. The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.